Targeting cancer with a multidrug nanoparticle
Using bottlebrush-shaped particles, researchers can identify and deliver synergistic combinations of cancer drugs.
MIT researchers develop an AI model that can detect future lung cancer risk
Deep-learning model takes a personalized approach to assessing each patient’s risk of lung cancer based on CT scans.
Compassion in the details
The late MIT Professor Angelika Amon was recognized as Committed to Caring for her generous and encompassing mentorship.
Enzyme “atlas” helps researchers decipher cellular pathways
Biologists have mapped out more than 300 protein kinases and their targets, which they hope could yield new leads for cancer drugs.
New tool can assist with identifying carbohydrate-binding proteins
Groundbreaking research can help alleviate the challenges affiliated with studying carbohydrates.
Honoring Salvador Luria, longtime MIT professor and founding director of the MIT Center for Cancer Research
Koch Institute event celebrates the new MIT Press biography “Salvador Luria: An Immigrant Biologist in Cold War America.”
Nanosensors target enzymes to monitor and study cancer
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
A new control system for synthetic genes
Researchers have developed a technique that could help fine-tune the production of monoclonal antibodies and other useful proteins.
Angela Koehler takes on the most challenging drug targets
Using biological, chemical, and engineering tools, she has developed strategies to attack molecules once thought to be “undruggable.”
Two first-year students named Rise Global Winners for 2022
Now in its second year, the Rise program targets exceptional teenage scholars from around the world for their potential as future change-makers.
A “door” into the mitochondrial membrane
Study finds the protein MTCH2 is responsible for shuttling various other proteins into the membrane of mitochondria. The finding could have implications for cancer treatments and MTCH2-linked conditions.
MIT biologist Richard Hynes wins Lasker Award
Hynes and two other scientists will share the prize for their discoveries of proteins critical for cellular adhesion.
Through mentorship, a deeper understanding of brain cancer metabolism grows
As an MSRP-Bio student in the Vander Heiden lab, Alejandra Rosario helped to reveal how cancer cells maintain access to materials they need to grow.
Using machine learning to identify undiagnosable cancers
A new model that maps developmental pathways to tumor cells may unlock the identity of cancers of unknown primary.
How different cancer cells respond to drug-delivering nanoparticles
The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer.